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ABSTRACT 
Human immunodeficiency virus (HIV) is major human disease which belongs to lentivirus 
(retrovirus). It is a major cause of acquired immunodeficiency syndrome (AIDS), a condition in humans in 
which progressive failure of the immune system allows life threatening opportunistic 
infections and cancers to thrive. A number of ways for transmission of HIV form human to another human 
through the blood, semen, vaginal fluid, pre-ejaculate or breast milk has been proved. An urgent need 
arises to establish antigen based immunodiagnostic for earlier monitoring of HIV and development of 
vaccines. In the present study, we have identified two major proteins i.e. ENV and NEF for identification 
of T-cell epitopes. We used two well established immunoinformatics tools Propred and Propred1 for 
identification. We identified a novel T-cell epitope for major histocompatibility complex class I and II with 
highest binding affinity. These finding provide a new insight for development of antigen based diagnostic 
kit and peptide based vaccine designing for controlling of AIDS.  
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1) INTRODUCTION 
Human immunodeficiency virus (HIV) is a single stranded 
RNA virus which is responsible to cause of acquired immune 
deficiency syndrome (AIDS). AIDS is defined in terms of 
either a CD4+ T cell count below 200 cells per microlitre or 
the occurrence of specific diseases in association with an HIV 
infection. The immunity of human body is weak. [1]. In a 
recent report suggested by Centers for Disease Control and 
Prevention (CDC) show that 1,148,200 Americans aged 13 
and older were living with HIV [2]. However, in the 2008-09 
National AIDS Control Organization has reported that 2.39 
million people live with HIV/AIDS in India [3]. While a more 
recent investigation by the Million Death Study Collaborators 
in the British Medical Journal and they estimated that 1.4-1.6 
million people suffer with AIDS [4]. There is an urgent need 
for controlling of AIDS by developing rapid, eco-friendly and 
cost effective immunodiagnostic capability. Therefore, two 
types of HIV have been characterized including HIV-1 and 
HIV-2. HIV-1 is the virus that was initially discovered and 
considered to be a more virulent, which is caused the majority 
of HIV infections worldwide [5]. The lower infectivity of 
HIV-2 compared to HIV-1 implies that fewer of those exposed 
to HIV-2 will be infected per exposure, because of its 
relatively poor capacity for transmission; HIV-2 is largely 
confined to West Africa [6].  
The culture of HIV is in laboratory is difficult and time 
consuming process; thus, a number of immunoinformatics tool 
have been developed for prediction of T and B cells epitopes 
any major virulent proteins. These tools have been developed 
on the basis of accessible and validated data which having 
specific algorithms [7]. Identification of T-cell epitopes in 
proteins of Human immunodeficiency virus (HIV) by using 
Propred [8] and Propred1 [9]. We had also used the Propred 
and Propred1 tools because these tools had covered maximum 
number of alleles. This is one of the very recent technique 
which is used for the identification of antigenic peptide and 
can be further used in diagnostic and vaccines development. 
The aim of present study was to identify and map the T-cell 
epitopes in the major putative proteins of HIV type 1. 
 
2)  MATHODOLOGY 
The sequence of two proteins i.e. NEF and ENV, of HIV type 
1 were retrieved from NCBI-GenBank and expected molecular 
weight and isoelectric point (pI) value of both the proteins 
were verified using Gene Runner and ExPasy software. 
Propred [8] and Propred1 [9] immunoinformatics tools were 
used for the identification of the T-cell epitopes in the protein 
sequence of NEF and ENV. These tools cover maximum 
number of human leukocyte antigen (HLA) comparison as 
compared to the other immunoinformatics tools. During 
epitopes prediction, we had considered 4% threshold with 
selecting 30 as the maximum binding score to HLA 
molecules. Finally, the predicted T-cell epitopes were used for 
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confirmation and homology matching with other amino acids 
by NCBI protein blast for the proportional study. 
 
3) RESULT AND DISCISSION 
HIV is global health problem and suppressed the human 
immune system that allows more susceptibility of infection. In 
this study, two proteins have a locus such as HIV-1 GP-1 was 
used for physicochemical analysis such as molecular weight, 
isoelectric point (Pi value) and antigenic nature. ENV protein 
showed the highest molecular weight 97.03kDa. Isoelectric 
point of these proteins was ranged between 5.99-8.88 .The 
physicochemical properties of the two proteins of HIV type-1 
were shown in Table 1. 
In the present study, we have used Propred tool for MHC class 
I prediction of T-cell epitopes in the proteins which include 
ENV and NEF, encoded by genome of HIV. The predicted 
epitopes, their amino acid position in the protein and their 
number of MHC class I binding allele are shown in Table 2.  
Additionally, we have used Propred-1 tool for MHC class II 
prediction of T-cell epitopes again in ENV and NEF proteins. 
The predicted epitopes, their amino acid position in the protein 
and their number of MHC class II binding allele are shown in 
Table 3.  
Similar approach has been previously used for T-cell epitopes 
prediction from human papillomavirus [10], tick borne 
encephalitis virus [11], influenza A virus [12] and 
mycobacterium tuberculosis [13]. 
Protein T-cell Epitope Amino acid 
position 













LRIVFAVLS 694-702 49 
VQLNTSVEI 285-293 13 
VVKIEPLGV 487-495 27 
FIMIVGGLV 684-692 7 
IRLVNGSLA 745-753 6 
IKQLQARIL 572-580 4 
IRIQRGPGR 306-314 8 
IRPVVSTQL 250-258 12 
LLNATAIAV 813-821 5 
VSLLNATAI 811-819 2 
VGGLVGLRI 688-696 4 
VVQGACRAI 831-839 3 
MRQAHCNIS 325-333 19 
LVGLRIVFA 691-699 25 
LGFLGAAGS 519-527 19 
LRAIEAQQH 555-563 13 
WKNDMVEQM 95-103 11 
IVGGLVGLR 687-695 3 
VRQGYSPLS 707-715 4 
LKNDTNTNS 133-141 14 
YKLDIIPID 176-184 4 
VTIGKIGNM 317-325 2 
LVNGSLALI 747-755 9 
MLLGMLMIC 19-27 9 
VVLVNVTEN 83-91 13 
VGIGALFLG 512-521 1 
Table 1: Physicochemical properties of different putative proteins of HIV TYPE 1  
Protein Designation Accession Number Molecular Weight (KDa) PI 
ENV NP_057856 97.23 9.17 
NEF NP_057857 23.47 5.99 
 
Table 2: The predicted epitopes in different putative proteins of HIV type 1 with reference to MHC molecules class I. 
Protein T-cell epitope Amino acid 
position 




VTENFNMWK 89-97 1 
KEYAFFYKL 171-179 2 
SFEPIPIHY 209-217 1 
KLTSCNTSV 192-200 2 
KLTPLCVSL 121-129 1 
QMHEDIISL 103-111 1 





LIHSLIEES 640-648 6 
LLIVTRIVE 774-782 13 
LFIMIVGGL 683-691 25 
LKNSAVSLL 806-814 3 
IRHIPRRIR 839-847 17 
IVFAVLSIV 696-704 3 
LRSLCLFSY 759-767 14 
VVIRSVNFT 269-277 26 
VLVNVTENF 84-92 2 
IRCSSNITG 442-450 5 
IHYCAPAGF 214-222 4 
LWYIKLFIM 678-686 1 
VQGACRAIR 832-840 4 
IVGGLVGLR 687-695 3 
FVTIGKIGN 316-324 16 
LLSGIVQQQ 543-551 6 
LSIVNRVRQ 701-709 9 
FNISTSIRG 158-167 10 
YLKDQQLLG 585-593 2 
FGNNKTIIF 352-360 8 
YIKLFIMIV 680-688 11 
YKLTSCNTS 190-198 7 
WNASWSNKS 609-617 3 
IKQIINMWQ 419-427 13 
IGKIGNMRQ 319-327 11 
IVQQQNNLL 547-555 9 
FFYCNSTQLF 382-390 3 
FAILKCNNK 222-230 6 
LKYWWNLLQ 792-800 17 
LLLIVTRIV 773-781 19 
VEINCTRPN 291-299 5 
VLSIVNRVR 700-708 3 
IWNHTTWME 621-629 5 
VGLRIVFAV 692-700 16 
INNYTSLIH 634-642 11 
LGIWGCSGK 592-600 1 
IVQLNTSVE 284-292 10 
LGMLMICSA 21-29 19 
MLMICSATE 23-31 9 
LMICSATEK 24-32 8 
LLGMLMICS 20-28 7 
YYGVPVWKE 38-46 4 
LLLNGSLAE 258-265 7 
WFNITNWLW 671-679 1 
VIRSVNFTD 270-278 1 
VFAVLSIVN 697-705 1 
IIVQLNTSV 283-291 2 
VQQQNNLLR 548-556 1 
FNSTWSTEG 395-403 1 
FNITNWLWY 672-680 3 
MICSATEKL 25-33 3 
FQTHLPTPR 716-724 3 
LIVTRIVEL 775-783 2 
YKVVKIEPL 485-493 2 
WYIKLFIMI 679-687 5 
YAFFYKLDI 172-180 20 
FYKLDIIPI 175-183 7 
VNVTENFNM 86-94 3 
WLWYIKLFI 677-685 23 
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VNGSLALIW 748-755 2 
IVTRIVELL 776-784 5 
LLQYWSQEL 798-806 5 
LYKYKVVKI 482-490 11 
LLQLTVWGI 564-572 12 
WNHTTWMEW 622-630 2 
YKYKVVKIE 483=491 8 
LQARILAVE 575-583 4 
LFSYHRLRD 764-772 8 
IVNRVRQGY 703-711 12 
WQKVGKAMY 426-434 4 
IRGKVQKEY 164-172 8 
VQARQLLSG 538-546 4 
MRVKEKYQH 483-491 22 
LLTRDGGNS 450-460 2 
VERYLKDQQ 582-590 2 
IIFKQSSGG 358-366 1 
WGIKQLQAR 570-578 3 
INMWQKVGK 423-431 13 
VELLGRRGW 781-789 4 
LLELDKWAS 659-667 9 
IMIVGGLVG 685-693 11 
LKPCVKLTP 115-123 8 
IVTHSFNCG 370-378 3 
LCLFSYHRL 762-769 3 
NEF 
WRFDSRLAF 182-190 25 
VEPDKIEEA 147-155 6 
LVPVEPDKI 144-152 3 
VIGWPTVRE 9-17 4 
VRYPLTFGW 132-140 5 
LWIYHTQGY 111-119 2 
YKLVPVEPD 142-150 3 
MRRAEPAAD 19-27 10 
FPVTPQVPL 67-75 2 
WSKSSVIGW 4-12 2 
YPLTFGWCY 134-142 2 
LTFGWCYKL 136-144 2 
MTYKAAVDL 78-86 2 
WCYKLVPVE 140-149 4 
WQNYTPGPG 123-131 5 
MGGKWSKSS 0-8 2 
FGWCYKLVP 138-146 2 
VRERMRRAE 15-23 7 
IHSQRRQDI 100-108 3 
LRPMTYKAA 75-83 4 
IHSQRRDI 100-107 2 
LIHSQRRQD 99-107 1 
 
4) CONCLUSION 
HIV is a major human health problem and a need arises for 
sensitive and specific diagnostic methods. Currently, in 
practical pathologists are doing immunoassays as the 
diagnostic measure, that require purified antigen which is 
possible by using culture of HIV or recombinant technology. 
To avoid this problem, bioinformatics is a good approach for 
prediction of epitopes without using wet laboratory practice. 
Our approach can help to accelerate virology research. These 
T-cell epitopes can be chemically synthesized and used as  
 
 
antigen for HIV diagnostic and it can be also used for 
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